HIV vaccine fails to Step up in test-of-concept trial

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1665, 2008-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials

By Kebba Anthony   Imami Nesrina   Bugembe-Lule Daniel   Senkaali David   Kaleebu Pontiano   Grosskurth Heiner   Gotch Frances  

Pharmacogenomics, Vol. 8, Iss. 4, 2007-04 ,pp. : 409-414

Future Medicine

Access to resources Recommend Favorite

Justification for Thai phase III HIV vaccine trial

By  

Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

NIAID decides not to go ahead with PAVE 100 HIV vaccine trial

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

AD vaccine fails to prevent neurodegeneration

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Joint Inferences on Vaccine Efficacy Against Infection and Disease with Application to the First HIV Vaccine Efficacy Trial

By Cai T.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 517-538

Taylor & Francis Ltd

Access to resources Recommend Favorite